Is there a possibility of missing cancer due to short core lengths in patients with benign pathology reports? Several studies did an in-depth analysis of core needle prostate biopsy length…
Read More
It’s that time of year again. If you are a 3rd-year medical student interested in applying for a pathology residency, chances are high that your application due dates are just…
Welcome to our second podcast episode! Today our guest pathologists Nicole Jackson, MD, and Brett Kurpiel, MD, each share their top three tips for pathology residency. Nicole Jackson is the…
LEHI, UT, May 16, 2023—Lumea, a leader in integrated digital pathology solutions, is pleased to announce that Acupath is partnering with Lumea to adopt the Lumea Viewer+™, leveraging its modular…
Abigail Diepeveen Senior Director of Growth & Digital Strategy Abigail Diepeveen is Senior Director of Growth & Digital Strategy at Lumea, where she has spent nearly a decade working at…
Genetic and other ancillary tests can be extremely useful resources for pathologists, clinicians, and patients. There are a wide variety of tests used in cancer diagnostics, prognostics, and theranostics. For…
Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023 — Lumea, a…
At the medical center of the University of Medicine and Pharmacy in Ho Chi Minh City, patients are not screened for bladder cancer using urine cytology because the pathology department…
Welcome to our first podcast! Today, our guest pathologists Jonhan Ho, MD, and Swikrity U Baskota, MD, share their top three things they didn’t know about becoming an attending pathologist….
The Digital Diagnostic Summit and Lumea are pleased to announce the start of a new pathology podcast: Ask a Pathologist. This podcast is a place where experienced pathologists come together…
